Zio XT ECG Monitoring System vs KardiaAI
AI Verdict
Choose Zio XT ECG Monitoring System if…
Choose Zio XT if your primary need is extended, continuous cardiac monitoring for up to 14 days with minimal patient burden. This system is ideal for detecting intermittent arrhythmias that might be missed by shorter monitoring periods, offering a comfortable, water-resistant wearable biosensor with expert AI analysis and review.
View Zio XT ECG Monitoring System →Choose KardiaAI if…
Choose KardiaAI if you require a powerful, FDA-cleared AI engine to integrate into your existing ECG devices, mobile applications, or web platforms for real-time rhythm analysis. This solution is best suited for developers and healthcare providers looking to enhance their own systems with medical-grade detection of various cardiac conditions like AFib, bradycardia, and tachycardia.
View KardiaAI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Zio XT ECG Monitoring System | KardiaAI |
|---|---|---|
| Pricing | Contact for pricing | Subscription-based for advanced features and services. |
| Deployment | Cloud-based (AWS EC2 platform), no on-premise hardware required. | Mobile app, cloud-based. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Zio XT ECG Monitoring SystemZio XT is designed as a complete, patient-friendly wearable system with no external wires, water resistance, and high reported patient compliance and satisfaction. This makes it directly usable and comfortable for patients over extended periods. KardiaAI, as an API library, relies on integration into other devices for end-user usability, making its direct 'usability' less applicable in this head-to-head comparison.
Clinical Value
Zio XT ECG Monitoring SystemBoth tools are FDA-cleared and offer medical-grade accuracy for cardiac arrhythmia detection. However, Zio XT provides continuous monitoring for up to 14 days, which offers a significant clinical advantage for capturing intermittent and elusive arrhythmias, potentially leading to a higher diagnostic yield. While KardiaAI lists a broad range of specific detections, the continuous, long-duration monitoring of Zio XT provides a distinct edge in comprehensive diagnostic capability.
Pricing & Value
Zio XT ECG Monitoring SystemZio XT offers transparent, per-patient service pricing for its comprehensive diagnostic monitoring, with clear rates for the UK and US Medicare. This provides a straightforward value proposition for healthcare providers. KardiaAI's listed pricing is for consumer subscriptions, and specific enterprise pricing for its AI library integration is not provided, making a direct comparison for enterprise value challenging.
Enterprise Readiness
Zio XT ECG Monitoring SystemBoth tools are FDA-cleared, HIPAA compliant, and offer BAAs, indicating foundational enterprise readiness. Zio XT, as a cloud-based system requiring no on-premise hardware, presents a more 'ready-to-deploy' solution for healthcare enterprises. KardiaAI, being an API library, offers flexibility but necessitates additional integration and development effort from the adopting enterprise.
Innovation
TieBoth tools demonstrate significant innovation in cardiac AI, albeit in different areas. Zio XT innovates in the holistic delivery of long-term, patient-friendly continuous monitoring with advanced AI for comprehensive diagnostics. KardiaAI's innovation lies in the breadth and modularity of its medical-grade AI algorithms, offering a versatile library for integration into various devices and platforms.
Support & Docs
TieBoth companies offer robust support and documentation tailored to their product models. iRhythm (Zio XT) provides extensive provider and patient support, including 24/7 assistance for billing and inventory management, along with comprehensive instructional manuals. AliveCor (KardiaAI) offers strong developer-focused support for its API/SDK integrations, including comprehensive technical documentation, an engaged engineering support team, and API documentation, which is crucial for its integration-centric nature.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Zio XT ECG Monitoring System | KardiaAI |
|---|---|---|
| Product Name | Zio XT ECG Monitoring System | KardiaAI |
| Company | iRhythm Technologies | AliveCor |
| Core Functionality | Wearable, single-lead ECG biosensor for up to 14 days of continuous cardiac monitoring, utilizing FDA-cleared AI and expert review for accurate arrhythmia detection and diagnosis. | FDA-cleared AI software library for analyzing ambulatory ECG rhythms, detecting various cardiac conditions like AFib, bradycardia, and tachycardia. |
| Primary Form Factor / Delivery | Wearable single-lead ECG biosensor (Zio biosensor) | AI software library (API) for integration into other ECG devices and software. |
| Specific Detections / Analysis | Arrhythmia detection and diagnosis (general). | Atrial fibrillation, bradycardia, tachycardia, normal sinus rhythm, Sinus Rhythm with Premature Ventricular Contractions (PVCs), Sinus Rhythm with Wide QRS, Sinus Rhythm with Supraventricular Ectopy (SVE), ECG noise filtering, noisy ECG detection. |
| Maximum Monitoring Duration | Up to 14 days of continuous monitoring. | Not specified |
Videos
Demos, reviews, and walkthroughs featuring Zio XT ECG Monitoring System and KardiaAI.
Frequently Asked Questions
More Comparisons
More matchups featuring Zio XT ECG Monitoring System or KardiaAI
Backers
Who funded each tool's parent company.